Loading...
Loading...
Synbio International, Inc.
Synbio International, Inc.. Spoken Alpha tracks SYIN's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks SYIN's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 9/10 quarters but stock falls 70% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for SYIN.
curl https://api.spokenalpha.com/v1/companies/SYIN| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.84 | $2.79 | +1.9% | -2.9% | -1.9% |
| Q4 FY2026 | $3.27 | $2.94 | +11.2% | -6.4% | -8.8% |
| Q3 FY2026 | $2.93 | $2.85 | +2.8% | +0.4% | +2.7% |
| Q2 FY2026 | $3.00 | $2.77 | +8.2% | -0.3% | +0.9% |
| Q1 FY2025 | $3.11 | $2.85 | +9.1% | -5.4% | -7.2% |
| Q4 FY2025 | $2.84 | $2.88 | -1.5% | -1.2% | +0.7% |
| Q3 FY2025 | $3.07 | $2.76 | +11.4% | -4.6% | -2.2% |
| Q2 FY2025 | $2.98 | $2.80 | +6.4% | +3.6% | +6.6% |
| Q1 FY2024 | $3.27 | $3.04 | +7.7% | +0.4% | +3.0% |
| Q4 FY2024 | $2.88 | $2.83 | +1.8% | -1.7% | -3.6% |